Harvard i-lab | The Other Side Speaker Series w/ Stéphane Bancel | Summary and Q&A

TL;DR

Mada Therapeutics, a revolutionary biotech company, is using mRNA therapy to create drugs that can be injected into the body to treat various diseases.

Key Insights

• 🇲🇬 Mada Therapeutics is using mRNA therapy to create revolutionary drugs.
• ❓ The company's focus on mRNA therapy offers a unique approach to treating diseases.
• 🤨 Mada Therapeutics has raised significant funding and made impressive advancements in bringing their candidates into clinical trials.
• 😀 The company faces challenges in drug delivery, but is actively exploring different methods to address this issue.

Transcript

um hi everyone my name is Alice Lee and uh yes you heard right it's Harvard Innovation Labs we are now plural and that's because uh in addition to the Harvard ey laab where you're you find yourself sitting right now we which serves current Harvard stud students take um explore entrepreneurship and Innovation at various stages we've grown this ecosy... Read More

Questions & Answers

Q: How does mRNA therapy work in treating diseases?

mRNA therapy involves injecting mRNA into the body, which allows the cells to produce proteins that can treat or address various disease conditions.

Q: What steps did Mada Therapeutics take to validate their science and secure funding?

Mada Therapeutics spent two years in stealth mode, validating their science with a small team before securing funding and initiating clinical trials.

Q: How does Mada Therapeutics differentiate itself from other biotech disruptors like CRISPR?

Mada Therapeutics focuses on using mRNA to create therapeutic proteins, while technologies like CRISPR focus on gene editing. Both technologies have their own unique applications in the field of biotechnology.

Q: How does Mada Therapeutics address the challenge of drug delivery for mRNA therapy?

Mada Therapeutics explores different delivery methods, including intramuscular injections, intradermal injections, and localized injections to target specific tissues or organs.

Summary & Key Takeaways

• Mada Therapeutics was founded in 2011 and has since raised over $1.2 billion in venture funding, focusing on mRNA therapy.

• The company has grown to include four spin-out ventures that address different disease states using the same mRNA technology.

• Mada Therapeutics has made significant progress in bringing their candidates into clinical trials and has been listed as a top disruptor in the industry.